申请人:MERCK SHARP & DOHME
公开号:WO2012096813A1
公开(公告)日:2012-07-19
Described herein are compounds of formula I. The compounds of formula I act as DGAT1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for hyperlipidemia, diabetes mellitus and obesity.
本文描述了式I的化合物。式I的化合物作为DGAT1抑制剂,可用于预防、治疗或作为高脂血症、糖尿病和肥胖的治疗药物。